TCM Biotech International Corp. (TPEX:4169)
Taiwan · Delayed Price · Currency is TWD 158.50
0.00 (0.00%)
Oct 31, 2025, 2:53 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 9.36 billion as of October 31, 2025. Its market cap has increased by 155.23% in one year.
Market Cap
9.36B
Enterprise Value
8.87B
Revenue
674.43M
Ranking
n/a
PE Ratio
346.51
Stock Price
158.50
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 9.36B, an increase of 584.15%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 9.36B | 173.75% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | 1.71B | 62.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |